يعرض 1 - 7 نتائج من 7 نتيجة بحث عن '"Yanai, Hidetoshi"', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 1
    Academic Journal
    Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA

    المؤلفون: Taniguchi, Yoshihiko, Tamiya, Akihiro, Osuga, Mitsuo, Isa, Shun-ichi, Nakamura, Keiichi, Mizumori, Yasuyuki, Shinohara, Tsutomu, Yanai, Hidetoshi, Nakatomi, Katsumi, Oki, Masahide, Mori, Masahide, Kuwako, Tomohito, Yamazaki, Koji, Shimada, Masahiro, Ando, Masahiko, Koh, Yasuhiro

    المساهمون: AstraZeneca

    المصدر: Investigational New Drugs ; ISSN 0167-6997 1573-0646

    الاتاحة: https://doi.org/10.1007/s10637-024-01500-9
    https://link.springer.com/content/pdf/10.1007/s10637-024-01500-9.pdf
    https://link.springer.com/article/10.1007/s10637-024-01500-9/fulltext.html

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status.

    المؤلفون: Taniguchi, Yoshihiko, Tamiya, Akihiro, Osuga, Mitsuo, Harada, Daijiro, Isa, Shun-ichi, Nakamura, Keiichi, Mizumori, Yasuyuki, Shinohara, Tsutomu, Yanai, Hidetoshi, Nakatomi, Katsumi, Oki, Masahide, Mori, Masahide, Kuwako, Tomohito, Yamazaki, Koji, Tamura, Atsuhisa, Ando, Masahiko, Koh, Yasuhiro

    المصدر: BMC Pulmonary Medicine; 8/24/2024, Vol. 24 Issue 1, p1-6, 6p

    مصطلحات موضوعية: EPIDERMAL growth factor receptors, NON-small-cell lung carcinoma, OVERALL survival, PROGRESSION-free survival, MULTIVARIATE analysis

    Full Text Finder

    أضف إلى المفضلة
  3. 3
    Academic Journal
    Sarcopenia in Resected NSCLC: Effect on Postoperative Outcomes

    المؤلفون: Nakamura, Ryota, Inage, Yoshihisa, Tobita, Rika, Yoneyama, Satoshi, Numata, Takeshi, Ota, Kyoko, Yanai, Hidetoshi, Endo, Takeo, Inadome, Yukinori, Sakashita, Shingo, Satoh, Hiroaki, Yuzawa, Kenji, Terashima, Toru

    المصدر: Journal of Thoracic Oncology ; volume 13, issue 7, page 895-903 ; ISSN 1556-0864

    الاتاحة: http://dx.doi.org/10.1016/j.jtho.2018.04.035
    https://api.elsevier.com/content/article/PII:S1556086418305975?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S1556086418305975?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  4. 4
    Academic Journal
    Epidermal Growth Factor Receptor Mutations: Effect on Volume Doubling Time of Non–Small-Cell Lung Cancer Patients

    المؤلفون: Nakamura, Ryota, Inage, Yoshihisa, Tobita, Rika, Mori, Kazuko, Numata, Takeshi, Yanai, Hidetoshi, Endo, Takeo, Ohtani, Haruo, Satoh, Hiroaki, Yuzawa, Kenji, Koizumi, Masanori, Ueki, Hamaichi

    المصدر: Journal of Thoracic Oncology ; volume 9, issue 9, page 1340-1344 ; ISSN 1556-0864

    الاتاحة: http://dx.doi.org/10.1097/jto.0000000000000022
    https://api.elsevier.com/content/article/PII:S1556086415306791?httpAccept=text/xml
    https://api.elsevier.com/content/article/PII:S1556086415306791?httpAccept=text/plain

    View record in BASE

    أضف إلى المفضلة
  5. 5
    Patent
    Magnetic recording medium with a back coat layer of nitrocellulose and polyurethane binder resins and which contains carbon black and titanium dioxide particles
    View record in USPTO Patent Grants

    أضف إلى المفضلة
  6. 6
    Academic Journal
    First report of ELUCIDATOR study: A prospective observational multicenter study on resistance mechanisms in patients with early disease progression during osimertinib.

    المؤلفون: Mizumori, Yasuyuki, Tamiya, Akihiro, Osuga, Mitsuo, Isa, Shun-ichi, Taniguchi, Yoshihiko, Nakamura, Keiichi, Harada, Daijiro, Shinohara, Tsutomu, Yanai, Hidetoshi, Nakatomi, Katsumi, Oki, Masahide, Mori, Masahide, Kuwako, Tomohito, Yamazaki, Koji, Tamura, Atsuhisa, Ando, Masahiko, Koh, Yasuhiro

    المصدر: Journal of Clinical Oncology; 2023 Supplement 16, Vol. 41, p3032-3032, 1p


    أضف إلى المفضلة
  7. 7
    Academic Journal
    Mechanisms of resistance and correlation between pre-treatment co-alterations and p-prognosis to osimertinib in chemo-naïve advanced non-small cell lung cancer.

    المؤلفون: Tamiya, Akihiro1 (AUTHOR), Osuga, Mitsuo2 (AUTHOR), Harada, Daijiro3 (AUTHOR), Isa, Shun-ichi4 (AUTHOR), Taniguchi, Yoshihiko1 (AUTHOR), Nakamura, Keiichi5 (AUTHOR), Mizumori, Yasuyuki6 (AUTHOR), Shinohara, Tsutomu7 (AUTHOR), Yanai, Hidetoshi8 (AUTHOR), Nakatomi, Katsumi9 (AUTHOR), Oki, Masahide10 (AUTHOR), Mori, Masahide11 (AUTHOR), Kuwako, Tomohito12 (AUTHOR), Yamazaki, Koji13 (AUTHOR), Tamura, Atsuhisa14 (AUTHOR), Ando, Masahiko15 (AUTHOR), Koh, Yasuhiro1,2,16 (AUTHOR) ykoh@wakayama-med.ac.jp

    المصدر: Lung Cancer (01695002). Sep2024, Vol. 195, pN.PAG-N.PAG. 1p.

    مصطلحات موضوعية: *EPIDERMAL growth factor receptors, *NON-small-cell lung carcinoma, *DELETION mutation, *CELL receptors, *DNA


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء